Milestone Pharmaceuticals Inc. announced that Richard C. Pasternak, M.D. has been appointed to its Board of Directors. He brings to Milestone over 40 years of clinical, academic, and biopharmaceutical industry experience in the area of cardiology. He will serve as a member of the Company's compensation committee. Dr. Pasternak recently retired from Cerenis Therapeutics where he served as Chief Executive Officer and Chair of the Board of Directors. Dr. Pasternak is currently a Clinical Professor at the Weill Cornell Medical College, and serves on the Boards of Anthos Therapeutics and Magenta Medical Ltd.